Terazosin Hydrochloride Anhydrous
- Product NDC
- 51079-938
- 11-digit product format
- 510790938
- Labeler code
- 51079
- Product ID
- 51079-938_9af1cfd2-0dea-a218-e053-2995a90a4efd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- terazosin hydrochloride anhydrous
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Mylan Institutional Inc.
- Application
- ANDA075140
- Marketing category
- ANDA
- Marketing start
- 2000-04-01
- Marketing end
- 2021-02-28
- Substance
- TERAZOSIN HYDROCHLORIDE ANHYDROUS
- Active strength
- 5 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51079-938-20 | 51079093820 | 100 BLISTER PACK in 1 CARTON (51079-938-20) > 1 CAPSULE in 1 BLISTER PACK (51079-938-01) | 100 blister pack | 2000-04-01 | 2021-02-28 | No | No | Current |